Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study
Anat Guz-Mark,Marina Aloi,Luca Scarallo,Matteo Bramuzzo,Johanna C Escher,Patrizia Alvisi,Paul Henderson,Iva Hojsak,Raffi Lev-Tzion,Wael El-Matary,Tobias Schwerd,Maya Granot,Malgorzata Sladek,Caterina Strisciuglio,Katalin E Müller,Christine Olbjørn,Christos Tzivinikos,Anat Yerushalmy-Feler,Koen Huysentruyt,Lorenzo Norsa,Irene Viola,Lissy de Ridder,Dror S Shouval,Sara Lega,Paolo Lionetti,Giulia Catassi,Amit Assa,Porto IBD working group of ESPGHAN
DOI: https://doi.org/10.1542/peds.2023-064546
2024-08-01
PEDIATRICS
Abstract:Objectives: This study described disease characteristics and long-term outcomes in patients diagnosed with very early onset inflammatory bowel disease (VEOIBD) (diagnosed before 6 years of age) and infantile-IBD (before 2 years). Methods: Cases from 21 centers worldwide diagnosed with VEOIBD (2008-2018), with minimum 2 years of follow-up, were retrospectively reviewed. Results: The cohort included 243 patients (52% males, median follow-up of 5.8 [range 2-18] years, including 69 [28%]) with infantile-IBD. IBD subtypes included Crohn's disease (CD), ulcerative colitis (UC), or IBD-unclassified (IBDU) in 30%, 59%, and 11%, respectively. Among patients with CD, 94% had colonic involvement, and among patients with UC/IBDU, 75% had pancolitis. Patients with infantile-IBD presented with higher rates of IBDU, lower hemoglobin and albumin levels, and higher C-reactive protein, and had lower response rates to first-induction therapy and corticosteroids therapy (P < .05 for all). Colectomy and diversion surgeries were performed in 11% and 4%, respectively, with no significant differences between age groups. Corticosteroid-free remission rates were 74% and 78% after 3 and 5 years, respectively, and 86% at end of follow-up. Genetic testing was performed in 96 (40%) patients. Among tested population, 15 (16%) were identified with monogenic disease. This group demonstrated lower response rates to induction therapies, higher rates of surgical intervention, and higher rates of major infections (P < .05 for all). Conclusions: Patients with VEOIBD, including infantile-IBD, exhibit low rate of complications and surgical interventions at the long term. Patients with monogenic IBD are at risk for more severe disease course.